OneSource Specialty [ONESOURCE] vs Blue Jet Healthcare [BLUEJET] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: OneSource Specialty Pharma Inc. wins in 6 metrics, Blue Jet Healthcare Ltd. wins in 11 metrics, with 0 ties. Blue Jet Healthcare Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | OneSource Specialty Pharma Inc. | Blue Jet Healthcare Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 936.63 | 23.87 | Blue Jet Healthcare Ltd. |
| Price-to-Book Ratio | 3.11 | 5.56 | OneSource Specialty Pharma Inc. |
| Debt-to-Equity Ratio | 21.93 | 1.64 | Blue Jet Healthcare Ltd. |
| PEG Ratio | 42.24 | -0.77 | OneSource Specialty Pharma Inc. |
| EV/EBITDA | 40.79 | 18.91 | Blue Jet Healthcare Ltd. |
| Profit Margin (TTM) | 1.42% | 27.88% | Blue Jet Healthcare Ltd. |
| Operating Margin (TTM) | -18.02% | 21.26% | Blue Jet Healthcare Ltd. |
| EBITDA Margin (TTM) | N/A | 21.26% | N/A |
| Return on Equity | -0.31% | 26.93% | Blue Jet Healthcare Ltd. |
| Return on Assets (TTM) | -0.24% | 21.53% | Blue Jet Healthcare Ltd. |
| Free Cash Flow (TTM) | $-1.96B | $-341.15M | Blue Jet Healthcare Ltd. |
| Dividend Yield | N/A | 0.22% | N/A |
| 1-Year Return | -20.38% | -46.26% | OneSource Specialty Pharma Inc. |
| Price-to-Sales Ratio (TTM) | 13.01 | 6.64 | Blue Jet Healthcare Ltd. |
| Enterprise Value | $195.90B | $65.92B | OneSource Specialty Pharma Inc. |
| EV/Revenue Ratio | 13.80 | 6.26 | Blue Jet Healthcare Ltd. |
| Gross Profit Margin (TTM) | 67.50% | 51.75% | OneSource Specialty Pharma Inc. |
| Revenue per Share (TTM) | $124 | $61 | OneSource Specialty Pharma Inc. |
| Earnings per Share (Diluted) | $1.72 | $16.90 | Blue Jet Healthcare Ltd. |
| Beta (Stock Volatility) | N/A | 0.37 | N/A |
OneSource Specialty Pharma Inc. vs Blue Jet Healthcare Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| OneSource Specialty Pharma Inc. | 0.68% | -6.58% | -11.52% | 8.72% | 0.44% | -9.19% |
| Blue Jet Healthcare Ltd. | -1.60% | 11.86% | 17.17% | 41.50% | -8.00% | -4.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| OneSource Specialty Pharma Inc. | -20.38% | -5.70% | -5.70% | -5.70% | -5.70% | -5.70% |
| Blue Jet Healthcare Ltd. | -46.26% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% |
Performance & Financial Health Analysis: OneSource Specialty Pharma Inc. vs Blue Jet Healthcare Ltd.
| Metric | ONESOURCE | BLUEJET |
|---|---|---|
| Market Information | ||
| Market Cap | ₹202.76B | ₹69.97B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 1,038,625 | 473,848 |
| 90 Day Avg. Volume | 610,058 | 572,203 |
| Last Close | ₹1,623.40 | ₹504.30 |
| 52 Week Range | ₹1,057.00 - ₹2,248.00 | ₹325.00 - ₹1,027.80 |
| % from 52W High | -27.78% | -50.93% |
| All-Time High | ₹2,248.00 (Jun 18, 2025) | ₹1,027.80 (Jul 21, 2025) |
| % from All-Time High | -27.78% | -50.93% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.26% | -0.40% |
| Quarterly Earnings Growth | N/A | -0.59% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.28% |
| Operating Margin (TTM) | -0.18% | 0.21% |
| Return on Equity (TTM) | 0.00% | 0.27% |
| Debt to Equity (MRQ) | 21.93 | 1.64 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹518.08 | ₹72.50 |
| Cash per Share (MRQ) | ₹14.56 | ₹23.76 |
| Operating Cash Flow (TTM) | ₹-2,152,760,000 | ₹899.31M |
| Levered Free Cash Flow (TTM) | ₹-179,710,000 | ₹3.05B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.22% |
| Last 12-Month Dividend | N/A | ₹1.20 |
Valuation & Enterprise Metrics Analysis: OneSource Specialty Pharma Inc. vs Blue Jet Healthcare Ltd.
| Metric | ONESOURCE (Apr 24, 2026) | BLUEJET (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 936.63 | 23.87 |
| Forward P/E | 42.24 | 22.70 |
| PEG Ratio | 42.24 | -0.77 |
| Price to Sales (TTM) | 13.01 | 6.64 |
| Price to Book (MRQ) | 3.11 | 5.56 |
| Market Capitalization | ||
| Market Capitalization | ₹202.76B | ₹69.97B |
| Enterprise Value | ₹195.90B | ₹65.92B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 13.80 | 6.26 |
| Enterprise to EBITDA | 40.79 | 18.91 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.37 |
| Book Value per Share (MRQ) | ₹518.08 | ₹72.50 |
Financial Statements Comparison: OneSource Specialty Pharma Inc. vs Blue Jet Healthcare Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ONESOURCE (2025) | BLUEJET (2025) |
|---|---|---|
| Revenue/Sales | 14.45B | 10.26B |
| Cost of Goods Sold | 4.35B | 4.70B |
| COGS % of Revenue | 30.1% | 45.8% |
| Gross Profit | 10.10B | 5.56B |
| Gross Margin | 69.9% | 54.2% |
| Research & Development | 20.49M | 15.52M |
| Operating Income (EBIT) | 1.90B | 3.60B |
| Operating Margin | 13.2% | 35.1% |
| EBITDA | 4.71B | 4.05B |
| EBITDA Margin | 32.6% | 39.5% |
| Pre-Tax Income | -670.66M | 4.06B |
| Pre-Tax Income % of Revenue | -4.6% | 39.6% |
| Income Tax | -497.85M | 1.01B |
| Income Tax % of Revenue | -3.4% | 9.8% |
| Net Income (Profit) | -179.71M | 3.05B |
| Profit Margin | -1.2% | 29.7% |
Balance Sheet & Liquidity Metrics
| Metric | ONESOURCE (2025) | BLUEJET (2025) |
|---|---|---|
| Cash & Equivalents | 1.56B | 329.79M |
| Total Current Assets | 10.86B | 10.06B |
| Total Current Assets % of Revenue | 75.2% | 98.0% |
| Total Current Liabilities | 11.14B | 2.56B |
| Total Current Liabilities % of Revenue | 77.1% | 24.9% |
| Long-Term Debt | 3.83B | 165.26M |
| Long-Term Debt % of Revenue | 26.5% | 1.6% |
| Total Shareholders Equity | 58.81B | 11.33B |
| Retained Earnings | -18.43B | 10.98B |
| Retained Earnings % of Revenue | -127.6% | 107.0% |
| Property, Plant & Equipment | 8.97B | 212.65M |
Cash Flow Statement Comparison
| Metric | ONESOURCE (2025) | BLUEJET (2025) |
|---|---|---|
| Operating Cash Flow | -2.15B | 899.31M |
| Operating Cash Flow % of Revenue | -14.9% | 8.8% |
| Capital Expenditures | N/A | -794.98M |
| Free Cash Flow | -1.96B | -341.15M |
| FCF Margin | -13.6% | -3.3% |
| Debt Repayment | -6.31B | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ONESOURCE | BLUEJET |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 114.64M | 173.47M |
| Float Shares | 70.43M | 33.13M |
| % Held by Insiders | 38.63% | 79.81% |
| % Held by Institutions | 26.67% | 1.90% |
| % Held by Public | 34.70% | 18.29% |
Dividend Analysis & Yield Comparison: OneSource Specialty Pharma Inc. vs Blue Jet Healthcare Ltd.
| Metric | ONESOURCE | BLUEJET |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.20 |
| Last 12-Month Dividend Yield | N/A | 0.22% |
| 3-Year Avg Annual Dividend | N/A | ₹0.73 |
| 3-Year Avg Dividend Yield | N/A | 0.19% |
| 3-Year Total Dividends | N/A | ₹2.20 |
| Ex-Dividend Date | N/A | Sep 19, 2025 |